pargyline has been researched along with Colonic Neoplasms in 2 studies
Pargyline: A monoamine oxidase inhibitor with antihypertensive properties.
Colonic Neoplasms: Tumors or cancer of the COLON.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Treatment with pargyline significantly increased the incidence of colon tumors in week 35." | 1.29 | Monoamine oxidase B inhibitor enhances experimental carcinogenesis in rat colon induced by azoxymethane. ( Baba, M; Iishi, H; Taniguchi, H; Tatsuta, M, 1994) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Satoh, M | 1 |
| Cherian, MG | 1 |
| Imura, N | 1 |
| Shimizu, H | 1 |
| Iishi, H | 1 |
| Tatsuta, M | 1 |
| Baba, M | 1 |
| Taniguchi, H | 1 |
2 other studies available for pargyline and Colonic Neoplasms
| Article | Year |
|---|---|
Modulation of resistance to anticancer drugs by inhibition of metallothionein synthesis.
Topics: Alkynes; Animals; Cisplatin; Colonic Neoplasms; Cysteine; Doxorubicin; Drug Resistance; Female; Fibr | 1994 |
Monoamine oxidase B inhibitor enhances experimental carcinogenesis in rat colon induced by azoxymethane.
Topics: Animals; Azoxymethane; Clorgyline; Colon; Colonic Neoplasms; Drug Synergism; Epithelium; Male; Norep | 1994 |